CAS 1333146-24-9

ILK-IN-2

CAS : 1333146-24-9

ILK-IN-2

Degré de pureté : ≥98%

Masse moléculaire : 533.59g/mol

Ref: 54-BUP09117

N-Methyl-3-(1-(4-(Piperazin-1-Yl)Phenyl)-5-(4'-(Trifluoromethyl)-[1,1'-Biphenyl]-4-Yl)-1H-Pyrazol-3-Yl)Propanamide

CAS : 1333146-24-9

N-Methyl-3-(1-(4-(Piperazin-1-Yl)Phenyl)-5-(4'-(Trifluoromethyl)-[1,1'-Biphenyl]-4-Yl)-1H-Pyrazol-3-Yl)Propanamide

Degré de pureté : 98%

Masse moléculaire : 533.59g/mol

Ref: 54-PC108730

ILK-IN-2

CAS : 1333146-24-9

ILK-IN-2 (OSU-T315) is a novel potent, orally active ILK (integrin-linked kinase) inhibitor with IC50 of 0.6 μM.

Formule : C₃₀H₃₀F₃N₅O

Degré de pureté : 99.30%

Couleur et forme : Solid

Masse moléculaire : 533.59

Ref: TM-T5488

ILK-IN-2

CAS : 1333146-24-9

ILK-IN-2 is a molecule that inhibits autophagy in leukemia cells. It has been shown to be effective in inhibiting the growth of meningioma and lymphocytic leukemia cells. ILK-IN-2 has also shown inhibitory properties against chronic lymphocytic leukemia and primary cells, which may be due to its ability to induce apoptosis by activating proapoptotic molecules such as Bax, Bak, and caspase-3. In addition, ILK-IN-2 has demonstrated anti-inflammatory properties that may lead to its use in autoimmune diseases.

Formule : C₃₀H₃₀F₃N₅O

Degré de pureté : Min. 95%

Masse moléculaire : 533.59 g/mol

Ref: 3D-IDC14624